Archives: Agenda

• Highlighting the fast-evolving development of multi-agent AI tools available
• Using humanoid robots to carry out motion-based tasks in the laboratory and the workplace
• Understanding how multi-agentic systems can support and improve different phases, operations, and processes of clinical trials
• Improving the design, enrolment, execution, analysis, results, and reporting in clinical trials with multi-agent systems

• Ensuring patient understanding of rights and informed consent
• Reaching underserved communities and reducing enrolment stigma
• Running trials more efficiently and effectively with patient burden in mind

• Ensuring study goals and expectations are agreed and aligned
• Monitoring budgets and dealing with additional costs
• Sharing processes for managing oversight with limited resource

• Creating site selection criteria and streamlining feasibility
• Attracting an academic organization’s attention to prioritize your need
• Considerations for contract negotiations and speeding up processing time scales
• Building relationships and providing two-way support

• Creating comparison processes for vendor selection
• Deciding and prioritising the most important criteria for study success
• Negotiating the best deal to ensure only paying for what you need
• Managing vendor relationships to ensure efficient and effective collaboration

Interactive roundtable sessions offer a unique opportunity to come together with your peers to share best practice and develop solutions to critical challenges facing the industry as a whole. Hosted by industry experts and each focused on a single issue, roundtables are an exciting, interactive way to build your personal network and learn from the experience and expertise of others.

Each roundtable session lasts for 30 minutes and delegates may attend up to 2 roundtables

Roundtable 1: Creating effective clinical vendor strategies and partnerships

Ryan Hovda, Head of Clinical Development Execution Excellence, Dompé

Roundtable 2: Sharing thoughts on diversity in clinical trials: how much focus remains on this?

Deborah Waltz, Vice President Quality Assurance, Cullinan Therapeutics

Roundtable 3: Running clinical trials inside or outside the USA: benefits and challenges

Ros Cheetham, Vice President Clinical Operations, MacroGenics

Roundtable 4: Creating a robust clinical trial design

Nicole Leedom, VP, Head of Clinical Operations, SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt Germany

Roundtable 5: Discussing how individuals are utilizing AI in clinical trials

Katherine Neblett, Global Program Director, AstraZeneca